Cheror

Cheror is a direct-to-consumer skincare label that concentrates on corrective serums, peptide-rich moisturizers, and mineral sunscreen. All formulas are fragrance-free, made in U.S. FDA-registered labs, and priced between $28 and $68—solidly mid-range. The line is sold only through cheror.com, which ships to North America, the EU, and parts of Asia within 5-7 days. The brand’s hook is “biocompatible buffering”: every active (retinal, 10% niacinamide, 15% azelaic acid) is encapsulated at a skin-neutral pH 5.5 and paired with a ceramide preload to cut irritation. Its best-known SKU, Triple-Barrier Serum, claims to rebuild the stratum corneum in 14 days; independent instrumental data posted on the site shows 42% transepidermal water-loss reduction. Refill pouches that snap into existing glass dropper bottles reduce plastic by 74%. Cheror speaks to science-minded millennials and Gen-Z shoppers who follow dermatology accounts on TikTok and Reddit, want clinic-level results without prescription hassle, and prioritize cruelty-free, vegan ingredients. Buyers typically have reactive or combination skin, dislike fragrance, and will pay $40 for a serum if transparent lab reports and 3D skin-scan before/afters are supplied. Competitors include dermatologist-founded “cleanical” brands and upscale pharmacy staples that sell actives in similar concentrations. Cheror differentiates by keeping the assortment under 10 SKUs, offering refill pricing 20% below first-purchase cost, and publishing third-party testing spreadsheets beside every product—tactics that position it as a lean, data-first alternative to broader, marketing-heavy ranges.